Doherty MD, Ding T, Koumpouras C, Telesco SE, Monast C, Das A, Brodmerkel C, Schloss PD.
2018.
Fecal microbiota signatures are associated with response to Ustekinumab therapy among Crohn’s Disease patients.
mBio.
9:
e02120-17.
DOI:
10.1128/mBio.02120-17.